ContraFect to Present at the 20th Annual Superbugs & Superdrugs UK Conference
14 mars 2018 07h00 HE
|
ContraFect Corporation
YONKERS, New York, March 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...